Celltrion

Main menu

Pipeline

Next Generation Biologics at Celltrion

Antibody Biosimilars

Candidate Category INN Major Indication
Remsima SC Infliximab Rheumatoid arthritis
CT-P16 Bevacizumab Colorectal cancer
CT-P05 Etanercept Rheumatoid arthritis
CT-P15 Cetuximab Colorectal cancer
CT-P14 Palivizumab Respiratory diseases
CT-P17 Adalimumab Rheumatoid arthritis

Antibody Biologics

Candidate Category Target Indication
CT-P27 Pandemic/Seasonal influenza
CT-P26 Breast cancer
CT-P25 Influenza
CT-P24 Hepatitis B virus
CT-P19 Rabies
위로 가기